As drug prices continue to rise and the affordability of medicines for patients remains out of reach, finding new and creative solutions that address affordability, while also rewarding innovation ...

"As CMS continues to evolve its drug price negotiation programme ... for the evaluation of Breo Ellipta and Trelegy Ellipta – which made £1.1 billion (almost $1.5 billion) and £2.2 billion ...

AZ has confirmed that the US regulator issued a complete response letter (CRL) for PT010, a triple therapy for COPD that would compete with GSK’s already-marketed Trelegy. A spokesman for AZ tol ...

But a generic version (and the active ingredient) of this popular medication, sildenafil, is widely available from several drug manufacturers at a fraction of the cost. Here’s more about this ...

Nov 22 (Reuters) - (This Nov. 22 story has been corrected to fix the list price of Pfizer's drug to about $268,000, not $225,000, in paragraph 3) The oral drug, branded as Attruby, was approved to ...

In such scenarios, the use of generic models that do not represent any particular OEM, but can represent the trend of equipment dynamic responses, can be highly valuable. Generic models of ...

The FDA will review an application to consider potential approval of Nubeqa plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer. The Food and Drug Administration (FDA) ...

Healthcare products provider RHEA Generics is committed to promoting affordable healthcare by offering generic medications that provide Filipinos with high-quality and cost-effective options. Neogin ...

Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes. By Rebecca Robbins Christina Jewett ...

New Africa – stock.adobe.com The drug addresses hypothyroidism, also known as an underactive thyroid, by replacing or providing more of a thyroid hormone naturally produced by the body.

The drug, which is named MariTide and delivered in a monthly injection, is some time away from being sold. By Gina Kolata The pharmaceutical manufacturer Amgen announced on Tuesday that an ...

Attruby — the generic name for the drug is acoramidis — helps stabilize the weak TTR, reducing the buildup of the faulty protein and slowing disease progression. It is the first treatment to ...